Teva And Alvotech Announce SELARSDI (ustekinumab-aekn) Injection Now Available In The U.S.
In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™ for all indications matching the reference product Stelara® (ustekinumab) and has granted a provisional determination of interchangeability for SELARSDI SELARSDI is the second …